Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 881–900 of 17,529 recalls

December 18, 2024· Alcon Research LLC

Recalled Item: Systane Lubricant Eye Drops

The Issue: Non-Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 18, 2024· Granules Pharmaceuticals Inc.

Recalled Item: Colchicine Capsules 0.6 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 18, 2024· Eugia US LLC

Recalled Item: medroxyPROGESTERone Acetate Injectable Suspension

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 18, 2024· AvKARE

Recalled Item: Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing...

The Issue: LABELING: LABEL MIX-UP

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 18, 2024· AvKARE

Recalled Item: Polyvinyl Alcohol Ophthalmic Solution 1.4%

The Issue: LABELING: LABEL MIX-UP

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 17, 2024· Amerisource Health Services LLC

Recalled Item: glipiZIDE

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
December 16, 2024· SHOPPERS- PLAZA

Recalled Item: FOUZEE SugarLin HERBAL FORMULA capsules

The Issue: Undeclared Metformin

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 16, 2024· FDC Limited

Recalled Item: Ciprofloxacin Ophthalmic Solution USP

The Issue: Defective container: Unable to get the solution out

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 16, 2024· SOMERSET THERAPEUTICS LLC

Recalled Item: Atropine Sulfate Ophthalmic Solution

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
December 13, 2024· Amerisource Health Services LLC

Recalled Item: Clobazam Tablets

The Issue: Presence of Foreign Tablets/Capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 25 mg

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 50 mg

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Regular Strength

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 12, 2024· Akron Pharma, Inc.

Recalled Item: Diphenhydramine HCl 25 mg

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Extra Strength 500 mg

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 12, 2024· Akron Pharma, Inc.

Recalled Item: Acetaminophen Extra Strength 500 mg

The Issue: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 12, 2024· Buy-Herbal

Recalled Item: Nhan Sam Tuyet Lien Truy Phong Hoan

The Issue: Undeclared Furosemide

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 12, 2024· GNMart LLC

Recalled Item: FORCE FOREVER 400mg Tablets

The Issue: Marketed without an approved NDA/ANDA. FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 12, 2024· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate

The Issue: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund